Effects of cannabidiol on brain excitation and inhibition systems; a randomised placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without autism spectrum disorder

There is increasing interest in the use of cannabis and its major non-intoxicating component cannabidiol (CBD) as a treatment for mental health and neurodevelopmental disorders, such as autism spectrum disorder (ASD). However, before launching large-scale clinical trials, a better understanding of t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuropsychopharmacology
Autors principals: Pretzsch, Charlotte Marie, Freyberg, Jan, Voinescu, Bogdan, Lythgoe, David, Horder, Jamie, Mendez, Maria Andreina, Wichers, Robert, Ajram, Laura, Ivin, Glynis, Heasman, Martin, Edden, Richard A. E., Williams, Steven, Murphy, Declan G. M., Daly, Eileen, McAlonan, Gráinne M.
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6784992/
https://ncbi.nlm.nih.gov/pubmed/30758329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41386-019-0333-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars